Samir Mehndiratta

918 total citations · 1 hit paper
28 papers, 744 citations indexed

About

Samir Mehndiratta is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Samir Mehndiratta has authored 28 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Samir Mehndiratta's work include Histone Deacetylase Inhibitors Research (10 papers), Synthesis and biological activity (6 papers) and Click Chemistry and Applications (5 papers). Samir Mehndiratta is often cited by papers focused on Histone Deacetylase Inhibitors Research (10 papers), Synthesis and biological activity (6 papers) and Click Chemistry and Applications (5 papers). Samir Mehndiratta collaborates with scholars based in Taiwan, India and Australia. Samir Mehndiratta's co-authors include Kunal Nepali, Preet Mohinder Singh Bedi, Sahil Sharma, Jing‐Ping Liou, Gurpreet Singh, Hsueh‐Yun Lee, Ramandeep Kaur, Manish Gupta, Shiow‐Lin Pan and Sunil Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Life Sciences.

In The Last Decade

Samir Mehndiratta

28 papers receiving 734 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions

2024 55 citations Saurav Kumar Jha, Gabriele De Rubis et al. Ageing Research Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samir Mehndiratta Taiwan	17	384	363	110	60	49	28	744
Qianbin Li China	18	295 0.8×	467 1.3×	157 1.4×	31 0.5×	135 2.8×	66	886
Zhouling Xie China	16	158 0.4×	277 0.8×	141 1.3×	38 0.6×	73 1.5×	46	643
Yongzhi Lu China	15	192 0.5×	344 0.9×	128 1.2×	77 1.3×	46 0.9×	34	765
Xiaohong Song China	12	100 0.3×	364 1.0×	107 1.0×	24 0.4×	19 0.4×	22	594
Chia-Chung Lee Taiwan	16	196 0.5×	298 0.8×	108 1.0×	30 0.5×	31 0.6×	24	494
Ritu Ojha India	15	267 0.7×	372 1.0×	94 0.9×	41 0.7×	19 0.4×	22	641
Yunlei Hou China	17	427 1.1×	254 0.7×	129 1.2×	54 0.9×	15 0.3×	64	734
Tsung‐Chih Chen Taiwan	16	219 0.6×	328 0.9×	133 1.2×	28 0.5×	46 0.9×	27	550
Ernst Binderup Denmark	14	117 0.3×	233 0.6×	118 1.1×	42 0.7×	30 0.6×	25	775
Hea-Young Park Choo South Korea	13	278 0.7×	278 0.8×	72 0.7×	40 0.7×	21 0.4×	20	632

Countries citing papers authored by Samir Mehndiratta

Since Specialization

Citations

This map shows the geographic impact of Samir Mehndiratta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Mehndiratta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Mehndiratta more than expected).

Fields of papers citing papers by Samir Mehndiratta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Mehndiratta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Mehndiratta. The network helps show where Samir Mehndiratta may publish in the future.

Co-authorship network of co-authors of Samir Mehndiratta

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Mehndiratta. A scholar is included among the top collaborators of Samir Mehndiratta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Mehndiratta. Samir Mehndiratta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mehndiratta, Samir, Gabriele De Rubis, Keshav Raj Paudel, et al.. (2024). The application of nanoparticles as advanced drug delivery systems in Attenuating COPD. Heliyon. 10(3). e25393–e25393. 20 indexed citations

Nath, R., Kylie A. Williams, Lisa Pont, et al.. (2024). Comparative pharmacokinetic evaluation of nanoparticle-based vs. conventional pharmaceuticals containing statins in attenuating dyslipidaemia. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(10). 7297–7306. 1 indexed citations

Jha, Saurav Kumar, Gabriele De Rubis, Yali Zhang, et al.. (2024). Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions. Ageing Research Reviews. 97. 102315–102315. 55 indexed citations breakdown →

Paudel, Keshav Raj, Manisha Singh, Gabriele De Rubis, et al.. (2024). Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies. Life Sciences. 352. 122859–122859. 8 indexed citations

Patel, Vyoma K., Samir Mehndiratta, Rashi Rajput, et al.. (2023). Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases. Food Bioscience. 56. 103205–103205. 7 indexed citations

Rubis, Gabriele De, Keshav Raj Paudel, Leander Corrie, et al.. (2023). Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(5). 2793–2833. 34 indexed citations

Chan, Michael, Vandana Patravale, John Disouza, et al.. (2023). Exploring the influence of the microbiome on the pharmacology of anti-asthmatic drugs. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(2). 751–762. 4 indexed citations

Mehndiratta, Samir, Bin Qian, Jian‐Ying Chuang, Jing‐Ping Liou, & Jean C. Shih. (2022). N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment. Journal of Medicinal Chemistry. 65(3). 2208–2224. 16 indexed citations

Mehndiratta, Samir, et al.. (2020). Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 74–84. 10 indexed citations

10.

Mehndiratta, Samir, Mei-Hsiang Lin, Chun‐Han Chen, et al.. (2019). N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression. European Journal of Medicinal Chemistry. 185. 111725–111725. 49 indexed citations

11.

Mehndiratta, Samir, Shiow‐Lin Pan, Sunil Kumar, & Jing‐Ping Liou. (2015). Indole-3-ethylsulfamoylphenylacrylamides with Potent Anti-proliferative and Anti-angiogenic Activities. Anti-Cancer Agents in Medicinal Chemistry. 16(7). 907–913. 4 indexed citations

12.

Naaz, Fatima, Sahil Sharma, Samir Mehndiratta, et al.. (2015). Screening of a library of 4-aryl/heteroaryl-4H-fused pyrans for xanthine oxidase inhibition: synthesis, biological evaluation and docking studies. Medicinal Chemistry Research. 24(8). 3334–3349. 70 indexed citations

13.

Mehndiratta, Samir, et al.. (2015). Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature. Recent Patents on Anti-Cancer Drug Discovery. 11(1). 2–66. 20 indexed citations

14.

Lai, Mei‐Jung, Hsueh‐Yun Lee, Li‐Hsun Chang, et al.. (2015). N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling. Journal of Medicinal Chemistry. 58(16). 6549–6558. 26 indexed citations

15.

Mehndiratta, Samir, Yi-Min Liu, Hsueh‐Yun Lee, et al.. (2014). Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity. European Journal of Medicinal Chemistry. 85. 468–479. 43 indexed citations

16.

Mehndiratta, Samir, Mei‐Jung Lai, Hsueh‐Yun Lee, et al.. (2014). Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents. Bioorganic & Medicinal Chemistry. 22(17). 4917–4923. 10 indexed citations

17.

Sharma, Sahil, et al.. (2014). Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(5). 730–736. 39 indexed citations

18.

Kaur, Ramandeep, Sahil Sharma, Gurpreet Singh, et al.. (2014). Anti-Cancer Pyrimidines in Diverse Scaffolds: A Review of Patent Literature. Recent Patents on Anti-Cancer Drug Discovery. 10(1). 23–71. 113 indexed citations

19.

Kumar, Sunil, et al.. (2014). Isolation of New Cyclohexyl Epoxide from the Fruits of Piper attenuatum. The Natural Products Journal. 3(4). 249–251. 1 indexed citations

20.

Lee, Hsueh‐Yun, Chia‐Ron Yang, Mei‐Jung Lai, et al.. (2013). 1‐Arylsulfonyl‐5‐(N‐hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors. ChemBioChem. 14(10). 1248–1254. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact